Skip to main content

Zyprexa Relprevv FDA Approval History

FDA Approved: Yes (First approved December 11, 2009)
Brand name: Zyprexa Relprevv
Generic name: olanzapine
Dosage form: for Extended Release Injectable Suspension
Company: Eli Lilly and Company
Treatment for: Schizophrenia

Zyprexa Relprevv (olanzapine) is a long-acting atypical antipsychotic for intramuscular injection indicated for the treatment of schizophrenia.

Development timeline for Zyprexa Relprevv

Dec 14, 2009Approval FDA Approves Lilly's Zyprexa Relprevv for Treatment of Schizophrenia in Adults

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.